Patrik Schadzek

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 5

Top Topics

Induced Apoptosis

Clinical Evaluation

Mesenchymal Stem Cells

Acute Lymphoblastic Leukemia

Top Venues

International journal of molecular sciences

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Sabrina Zippel, Nadine Dilger, Chandralekha Chatterjee, Annamarija Raic, Gerald Brenner-Weiß, Patrik Schadzek, Bastian Ernst Rapp, Cornelia Lee-Thedieck
A parallelized, perfused 3D triculture model of leukemia for in vitro drug testing of chemotherapeutics. Biofabrication 14 (3) (2022)
Anne Dierks, Corinne Vanucci-Bacqué, Anne-Marie Schäfer, Tina Lehrich, Frederike Ruhe, Patrik Schadzek, Florence Bedos-Belval, Anaclet Ngezahayo
The Bioactive Phenolic Agents Diaryl Ether CVB2-61 and Diarylheptanoid CVB4-57 as Connexin Hemichannel Blockers. Pharmaceuticals (Basel, Switzerland) 15 (10) (2022)
Nina Friese, Mattis Benno Gierschner, Patrik Schadzek, Yvonne Roger, Andrea Hoffmann
Regeneration of Damaged Tendon-Bone Junctions (Entheses)-TAK1 as a Potential Node Factor. International journal of molecular sciences 21 (15) (2020)
Patrik Schadzek, Yannick Stahl, Matthias Preller, Anaclet Ngezahayo
Analysis of the dominant mutation N188T of human connexin46 (hCx46) using concatenation and molecular dynamics simulation. FEBS open bio 9 (5) (2019)
Patrik Schadzek, Doris Hermes, Yannick Stahl, Nadine Dilger, Anaclet Ngezahayo
Concatenation of Human Connexin26 (hCx26) and Human Connexin46 (hCx46) for the Analysis of Heteromeric Gap Junction Hemichannels and Heterotypic Gap Junction Channels. International journal of molecular sciences 19 (9) (2018)